Description:

Molecular imaging is a field of medical imaging that focuses on imaging molecules of medical interest within living patients. This is in contrast to conventional methods for obtaining molecular information from preserved tissue samples, such as histology. Molecular imaging procedures which are non-invasive, safe, and painless are used to diagnose and manage the treatment of cancer, heart disease, brain disorders such as Alzheimer's and Parkinson's disease, gastrointestinal disorders, lung disorders, bone disorders, kidney and thyroid disorders, and more. Molecular imaging procedures are noninvasive, safe, and painless. How does molecular imaging work? When disease occurs, the biochemical activity of cells begins to change. For example, cancer cells multiply at a much faster rate and are more active than normal cells. Molecular Imaging (MI) is a growing biomedical research discipline that enables the visualization, characterization, and quantification of biological processes taking place at the cellular and subcellular levels within intact living subjects, including patients.

Molecular imaging is a very important diagnostic tool in the early assessment, risk stratification, evaluation, and follow-up of patients with neurological diseases, such as tumors, dementias (Alzheimer's and others), movement disorders, seizure disorders, and psychiatric disorders. The main advantages of optical imaging approaches compared to other imaging methods are their safety, straightforward use, and cost-effectiveness. The main drawback, however, has to deal with the presence of high scattering and high absorption in living tissues.

Functional imaging is the study of human brain function based on analysis of data acquired using brain imaging modalities such as Electroencephalography (EEG), Magnetoencephalography (MEG), functional Magnetic Resonance Imaging (fMRI), Positron Emission Tomography (PET) or Optical Imaging. There are five imaging modalities available for molecular imaging, including X-ray computed tomography imaging (CT), optical imaging (OI), radionuclide imaging (involving PET and SPECT), ultrasound (US) imaging, and magnetic resonance imaging (MRI). The disadvantages of molecular imaging include limitations in imaging that are dependent on specific tumor locations, e.g., soft tissue cannot be imaged using CT scans; ultrasound imaging cannot be performed on the lungs or bone; there are often drawbacks regarding spatial resolution.

Journal is now accepting manuscripts for volume 6 for the year 2021. We publish a minimum of 5 and a maximum of 20 articles per issue every month. Submissions to our journal are given high priority during the process.

You can submit the manuscript as an email attachment to Medicalsci@scholarlymed.comor online at https://bit.ly/3zuz9Bd